Explore the IMF’s 2022 Results in Our Impact Report


Explore the IMF’s 2022 Results in Our Impact Report The IMF continues to keep patients at the center of everything we do. With this in mind, we invite you to explore the results the IMF had in our 2022 Impact Report, available to download now. When you click on the burgundy words within the document, you can learn more on each topic.


Register Now for the February 1st Virtual Regional Community Workshop The IMF will host a Virtual Regional Community Workshop for the Northeast and Southeast Regions on Wednesday, February 1, 2023, at 2:30 p.m. PST / 4:30 p.m. CST / 5:30 p.m. ET. Craig Cole, MD (Michigan State University, Breslin Cancer Center —Lansing, MI) and David Vesole, MD, PhD, FACP (Hackensack University Medical Center, John Theurer Cancer Center — Hackensack, NJ) will provide an introduction to myeloma as well as discuss upfront treatments at diagnosis, maintenance therapy, relapse information, and clinical trials. IMF Nurse Leadership Board member Kimberly Noonan, DNP, ANP-BC, AOCN (Dana Farber Cancer Institute — Boston) will talk about managing side effects and symptoms of myeloma and its treatments. After each presentation with the experts, attendees will have ample time to ask questions.


Registration Is Now Open for the Patient and Family Seminar in Boca Raton, FL Back in person for the first time since 2019, the International Myeloma Foundation (IMF) is excited to announce that the 2023 Boca Raton Patient and Family Seminar is taking place on March 17-18, 2023, in Boca Raton, Florida. In the coming days, the IMF will announce our expert speaker lineup for the upcoming Boca Raton Patient and Family Seminar. We promise you will not want to miss this unique opportunity to hear from top myeloma experts from around the world. In-person seating is limited; register today before attendance is full.


Watch the Replay: Dr. Joseph Mikhael Discusses Research on Myeloma Disparities from ASH 2022 Earlier this month on Facebook Live, IMF Chief Medical Officer Dr. Joseph Mikhael discussed the latest research on disparities in myeloma presented at the 64th American Society of Hematology Meeting and Exposition.


First in a Series of Videos on Bispecific Antibodies In the coming weeks, the IMF will release a series of videos that take a deeper dive into bispecific antibodies. In the first of these videos, IMF Chief Medical Officer Joseph Mikhael explains the basics of the immune system, including Natural Killer (NK) cells, and T cells. He discusses antibody immunity, or the “complicated machinery of patient’s own immune system to target or kill cells,” which is called immunotherapy.


Selected Myeloma Expert Video from a Series Filmed Live at ASH 2022 The IMF speaks with leading myeloma experts live from the 64th American Society of Hematology Annual Meeting and Exposition. In this video, Dr. Ástrún Helga Jónsdóttir, University of Iceland, presents the results of an iStopMM study regarding hypercalcemia in individuals with Monoclonal Gammopathy of Undetermined Significance (MGUS). Visit all of IMF’s coverage from ASH at mmsm.link/ASH


#ASKDRDURIE \| Dr. Durie's Weekly Web Video Series Are mass spectrometry and next-generation flow useful tests to evaluate minimal residual disease (MRD)?

Week in Review Blogs by Dr. Durie

Ask Dr. Durie Videos

Online Patient Forum

Smart Patients: Join the Conversation

Clinical Trial Fact Sheets

Phase II Relapsed or Refractory Venetoclax Trial (Accruing)

CANOVA Trial (Fully Accrued)

Phase I/II Trial Using a Venetoclax Combination With or Without Bortezomib (Fully Accrued)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

Ongoing & Upcoming Events

Register Now
15th Annual Miles for Myeloma

Donate Now
Mackenzie’s March for Myeloma

Donate Now
Racing for the Cure

Webinar Replays

Watch the Replay
Top Myeloma Research Presented at ASH 2022

Watch the Replay
IMWG Conferences Series at ASH 2022

Watch the Replay
IMF Patient and Family Webinar

See also, all of our events.

We Thank Our Sponsors:

Amgen, Bristol Myers Squibb, GSK, Janssen Oncology,
Legend Biotech, and Takeda Pharmaceuticals U.S.A., Inc.

We also thank individuals like you for your continued support!

Join the conversation at The International Myeloma Foundation

Facebook: /Myeloma | Twitter @IMFMyeloma | Instagram @IMFmyeloma

www.myeloma.org

This email was sent to by:
The International Myeloma Foundation
4400 Coldwater Canyon Ave., Suite 300
Studio City, CA 91604
Connect with the IMF InfoLine
1-800-452-2873

We respect your privacy and your preferences for communications of this nature.
Home • Unsubscribe • Manage Subscriptions • Privacy Policy

View as web page